EHA-SWG Scientific Meeting on Integrated Cell Tracking in Oncohematology: Diagnosis, Targeted Therapy and Residual Disease

Dates: November 10-12, 2022
Location: Bordeaux, France
Chair: MC Béné

Online registration is open, click here to register!

This is the third time EHA is collaborating with the EHA Scientific Working Group on Diagnosis in hematological diseases, to bring you the latest in laboratory hematology. The program will contain a mixture of expert lectures, patient input and presentations from submitted abstract authors.  

Target audience

Senior or junior hematologists, laboratory or clinical, interested in updating their knowledge on the integrated diagnosis of hematological malignancies.

Key dates


Online registration is now open and you can now benefit from a special 'teaser' fee by registering before April 1, 2022 (23:59). To learn more about the registration details, click here.


This meeting will cover the following topics related to oncohematology: diagnosis, targeted therapy and residual disease:

  • Tools of the trade
  • Blast cells
  • CD5+ B-lymphocytes
  • Lymphoma cells
  • CML cells
  • Myelodysplastic cells (MDS) and myeloproliferative neoplasms (MPN)
  • Other cells

The complete program is available here.

Abstract & case submission

Abstract and case submission is an important part of EHA-SWG Scientific Meeting programs. As a participant,  you have the opportunity to submit an abstract or clinical case for this meeting, and (if accepted) discuss it with the international faculty and peers.

A selection of abstracts and clinical cases will be eligible for acceptance during the meeting, the presentation format will be in the form of oral presentations or poster presentations. Presenting authors will receive a separate invitation.

More information on the abstract and case submission will be available soon.

Learning objectives

After attending this EHA-SWG Scientific Meeting, delegates will be able to:

  • know about current diagnostic tools,
  • understand the targets of treatments,
  • understand measurable residual disease,
  • get a notion of the necessity of integrated diagnosis, and
  • get updated on therapies by other SWG members (clinical).


There are various opportunities to support this meeting. For more information please send an email to or check the sponsorship page.

EBAH CME Accreditation

EBAH accredited stamp DEF2

Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.